Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - large image1
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - image1
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - image2
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - image3
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - image4
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - image5
Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. buy - image6

Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.

TDS 1851 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShenZhen

Brand:

QiangTai

Packaging:

5/10/15/20/30/40/50/60mg/vial,10vials/box

Price valid (until):

2026-02-22

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Description

    Sales manager: CoCo
    WhatsApp: +852 6589 3435
    Email: qwrrafrw15463@outlook.com


      Wholesale Price 10mg 20mg 30mg Tirzepatide Weight Loss  


    Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 1

    Tirzepatide   is a peptide-based medication that has garnered significant attention in the field of diabetes management. As a member of the glucagon-like peptide-1 (GLP-1) receptor agonist class, Tirzepatide offers a novel approach to addressing the complexities of type 2 diabetes mellitus (T2DM). This peptide-based therapy has demonstrated promising results in clinical trials, showcasing its potential to revolutionize diabetes treatment.

      The therapeutic potential of Tirzepatide extends beyond glycemic control, with emerging evidence suggesting its utility in addressing comorbidities commonly associated with T2DM. Preclinical studies have indicated potential benefits of Tirzepatide in preserving beta-cell function, reducing inflammation, and improving cardiovascular function, highlighting its broader impact on metabolic health. These findings underscore the transformative role of peptide-based therapies like Tirzepatide in reshaping the landscape of diabetes care.

      In clinical practice, Tirzepatide 10mg is typically administered via subcutaneous injection once weekly, allowing for sustained pharmacological activity and consistent glucose-lowering effects throughout the treatment period. The recommended starting dose and titration schedule may vary based on individual patient factors, including baseline glycemic control, renal function, and concomitant medications. Close monitoring of glycemic parameters and adherence to treatment guidelines are essential to optimize therapeutic outcomes and minimize the risk of adverse events.


    Items Specifications

    Product Name

    Tirzepatide

    CAS number

    2023788-19-2

    Purity

    99%

    Molecular Weight

    4813.527g/mol

    Molecular Formula

    C225H348N48O68

    Application


    Weight loss

    Appearance

    White Lyophilized powder


      Product Function


       The addition of GIP which anatagonizes the central effects of GLP-1 to cause nausea is designed to improve tolerability and also allow for more aggressive dosing with increased systemic exposure. A recent post-hoc analysis showed significantly decreased NASH-related biomarkers and increased adiponectin in patients with T2DM

      The weight-reducing actions of the GIPR-GLP1R co-agonist tirzepatide.Considerable interest is focused on the mechanisms of action of tirzepatide, a highly effective GIPR-GLP1R co-agonist that produces superior reductions in HbA1c and body weight, relative to that achieved with 1 mg once weekly of semaglutide in people with T2D. The GIPR is expressed in multiple regions of the mouse and human brain, in subsets of neurons and glial cells, with some hypothalamic and hindbrain cells exhibiting co-expression of the GIPR and GLP1R. Chemogenetic activation of GIPR + cells in the mouse hypothalamus acutely reduced food intake; however, co-administration of exendin-4 did not produce an additive reduction of food intake when compared to either intervention alone.


    Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 2


      Product Application  


    •   1.Helps slow food leaving your stomach
    •   2.Helps prevent your liver from making too much sugar
    •   3.Helps the pancreas produce more insul when your blood sugar levels are high
    •   4.Can help control blood glucose
    •   5.Can reduce hyperglycemia, especially after meals
    •   6.Can reduce fasting insul and fasting glucose
    •   7.Can reduce hemoglobin A1c
    •   8.Can decrease appetite and caloric intake, while inhibiting weight gain
    •   9.Has been shown to lower triglyceride levels and oxidative stress from high LDL

    • Shop High Quality CAS 2023788-19-2 GLP-1 Tirzepatide 5mg 10mg 15mg 20mg 30mg 60mg Vials Tirzepatide Raw Powder CAS 2023788-19-2-Detailed Image 2 Shop High Quality CAS 2023788-19-2 GLP-1 Tirzepatide 5mg 10mg 15mg 20mg 30mg 60mg Vials Tirzepatide Raw Powder CAS 2023788-19-2-Detailed Image 3 Shop High Quality CAS 2023788-19-2 GLP-1 Tirzepatide 5mg 10mg 15mg 20mg 30mg 60mg Vials Tirzepatide Raw Powder CAS 2023788-19-2-Detailed Image 4



    • Shop High Quality CAS 2023788-19-2 GLP-1 Tirzepatide 5mg 10mg 15mg 20mg 30mg 60mg Vials Tirzepatide Raw Powder CAS 2023788-19-2-Detailed Image 22


    Shop High Quality CAS 2023788-19-2 GLP-1 Tirzepatide 5mg 10mg 15mg 20mg 30mg 60mg Vials Tirzepatide Raw Powder CAS 2023788-19-2-Detailed Image 23





      Company Profile


    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

      Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 8 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 9 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 10 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 11 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 12


      Why choose us?   


    Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 8


      Product Images  


    Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 9 Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 10 Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 11 Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 12 Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 13


      Tracking Number  


    Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 15 Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 16 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 21 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 22


      Customer feedback  


    Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 20


      Exibition  


    Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 23 Shop Weight Loss Peptide GLP-1 CAS 2023788-19-2 Tirzepatide Hot Selling Fast Delivery-Detailed Image 24 Shop Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity.-Detailed Image 26


    Certificates
    • Tirzepatide Is The First And Only Dual GIP and GLP-1 Receptor Agonist For Type 2 Diabetes And Obesity. Certificates 1

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide,Retatrutide

    Location:

    No. A5121, Enterprise Development Service Center, Xiji Town, Tongzhou District, Beijing

    Payment Terms:

    100% TT in advance

    Average lead Time:

    2

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2021

    Certifications:

    business license,Semaglutide,Ti rzepatide,Retatrutide

    Company Profile

    Beijing Qiangtai Biotechnology Co., Ltd. is a professional manufacturer specializing in peptide research, development, and production. With years of experience in peptide synthesis and purification, we provide high-quality peptide products for scientific research and industrial applications.

    Our facilities are equipped with advanced synthesis and analytical instruments, and our production processes follow strict quality control standards to ensure product consistency and reliability. Each batch is tested to meet defined specifications before delivery.

    We focus on long-term cooperation and customized solutions, supporting clients with stable supply, flexible packaging options, and efficient communication. As we expand into the international market, we are committed to building trusted partnerships with global customers through transparent operations and dependable service.

  • Inquiry History
    1851 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide CAS 2023788-19-2 99% White powder

    Jun 30, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Tirzepatide 99% white powder 99% powder 2023788-19-2 HSD

    1000 G Jun 27, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    10  Aug 3, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    United States

    Buy Tirzepatide 5mg 10mg 15mg Great Reviews 2023788-19-2 99% powder 001 HD

    1 KG Jul 3, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.